Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 39.93B | 36.99B | 29.05B | 34.16B | 35.36B | 36.75B |
Gross Profit | 8.01B | 7.60B | 5.59B | 6.41B | 6.64B | 6.93B |
EBITDA | 3.75B | 4.51B | 2.80B | 3.48B | 3.15B | 3.50B |
Net Income | 2.32B | 2.06B | 1.27B | 1.81B | 1.62B | 1.94B |
Balance Sheet | ||||||
Total Assets | 40.73B | 44.77B | 38.72B | 38.79B | 39.11B | 37.55B |
Cash, Cash Equivalents and Short-Term Investments | 9.13B | 17.01B | 14.68B | 11.88B | 11.77B | 11.26B |
Total Debt | 0.00 | 170.78M | 153.24M | 213.09M | 134.25M | 124.59M |
Total Liabilities | 8.86B | 13.75B | 10.76B | 11.23B | 13.11B | 13.15B |
Stockholders Equity | 31.26B | 30.29B | 27.29B | 26.96B | 25.44B | 23.82B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 2.66B | 2.94B | 894.26M | 1.52B | 2.53B |
Operating Cash Flow | 0.00 | 3.62B | 4.34B | 2.11B | 2.11B | 3.23B |
Investing Cash Flow | 0.00 | -874.11M | -774.84M | -1.32B | -714.19M | -974.00M |
Financing Cash Flow | 0.00 | -621.26M | -958.39M | -691.19M | -604.49M | -635.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥24.67B | 7.19 | 6.38% | 0.36% | 248.87% | ||
74 Outperform | ¥15.64B | 7.15 | 3.68% | -5.40% | ― | ||
72 Outperform | ¥16.47B | 6.72 | 6.19% | 8.72% | 16.57% | ||
65 Neutral | ¥23.09B | 31.23 | 4.38% | 1.74% | -82.49% | ||
64 Neutral | £1.68B | 10.24 | 6.12% | 3.34% | 0.55% | -32.84% | |
52 Neutral | ¥16.48B | ― | 3.52% | 0.66% | -340.28% | ||
46 Neutral | ¥22.07B | ― | 3.48% | -1.68% | -240.66% |